Condition
Cigarette Use
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed3
Enrolling By Invitation1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06787937Not ApplicableRecruiting
Communicating About Nicotine Reduction in Cigarettes
NCT06988371Not ApplicableCompleted
Responses of Adults Smoking Nondaily and Daily in the Experimental Tobacco Marketplace
NCT07010601Not ApplicableCompleted
Tobacco Product Susceptibility and Substitutability by Rurality and Alcohol Use
NCT05275582Not ApplicableCompletedPrimary
Developing a Team-Delivered Intervention for Smoking and Hazardous Drinking for Primary Care Veterans With Cardiovascular Diseases
NCT06234722Not ApplicableEnrolling By Invitation
Modeling Tobacco Regulatory Impacts in Appalachia Using the Experimental Tobacco Marketplace
Showing all 5 trials